Get Started

KYNB

NASD Kyntra Bio, Inc.
Nov 6, 2026 · 2:13 AM ET EOD Market Closed

$3.66 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.66, $0.48 below the day’s high of $4.14

YTD change
-61.47%
vs 20-day SMA
-27.58%
vs 200-day SMA
-47.95%

Price ranges

Previous day
$3.96 $4.87
open $4.46 close $3.96
-$0.50 (-11.21%)
Today
$3.60 $4.14
open $3.96 now $3.66
-$0.30 (-7.58%)
Past week
$3.96 $4.87
from $4.72 now $3.66
-$1.06 (-22.46%)
Past month
$3.96 $6.34
from $6.13 now $3.66
-$2.47 (-40.29%)
This year
$3.60 $9.70
from $9.50 now $3.66
-$5.84 (-61.47%)

Price & Performance

-3.44 (-48.45%) / 6M

$3.27$5.16$7.05$8.94May 5Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 67.9% away from all-time highs of $11.39
  • KYNB is down 61% since the beginning of the year
  • KYNB is down 61% over the past 12 months
  • KYNB is down 40% over the past 1 month
  • 2% of all KYNB investors are betting against KYNB

KYNB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -61.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.96
Earnings momentum +183.4% Quarterly EPS growth
Quarterly change +183.4%

Valuation

P/E ratio 0.10
Enterprise value $-53287900.0
Beta 2.10

Balance sheet & scale

IncomeN/A
Revenue$4.6M
Cash$91.3M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $14.8M

Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.28 -3.80%
MRNA Moderna, Inc. $241.46 -6.55%
RVMD Revolution Medicines, Inc. $177.65 -11.04%
ROIV Roivant Sciences Ltd. $36.62 -4.21%
BNTX BioNTech SE Sponsored ADR $85.86 -5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.